

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium movement (GO:0003341) | 8.43816268 |
| 2 | motile cilium assembly (GO:0044458) | 8.33264327 |
| 3 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 7.56150474 |
| 4 | epithelial cilium movement (GO:0003351) | 7.13232596 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.15968656 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.15968656 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.15968656 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 6.15968656 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.15968656 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.15968656 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.77357361 |
| 12 | axoneme assembly (GO:0035082) | 5.49600220 |
| 13 | primary alcohol catabolic process (GO:0034310) | 5.48651063 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.11221861 |
| 15 | response to host immune response (GO:0052572) | 5.11221861 |
| 16 | response to peptidoglycan (GO:0032494) | 5.02595513 |
| 17 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.93184867 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.86889830 |
| 19 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.78297387 |
| 20 | cellular extravasation (GO:0045123) | 4.72353193 |
| 21 | response to host (GO:0075136) | 4.59926215 |
| 22 | response to host defenses (GO:0052200) | 4.59926215 |
| 23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.59926215 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.57936675 |
| 25 | ethanol metabolic process (GO:0006067) | 4.55783115 |
| 26 | neutrophil activation (GO:0042119) | 4.55312226 |
| 27 | neutrophil mediated immunity (GO:0002446) | 4.55309212 |
| 28 | left/right pattern formation (GO:0060972) | 4.50037314 |
| 29 | tolerance induction (GO:0002507) | 4.44476878 |
| 30 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.43625787 |
| 31 | vitamin transmembrane transport (GO:0035461) | 4.35945021 |
| 32 | granulocyte activation (GO:0036230) | 4.34201233 |
| 33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.33405497 |
| 34 | respiratory burst (GO:0045730) | 4.32644764 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29389943 |
| 36 | response to xenobiotic stimulus (GO:0009410) | 4.16679832 |
| 37 | leukocyte aggregation (GO:0070486) | 4.16215814 |
| 38 | detection of other organism (GO:0098543) | 4.14304242 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 4.13029559 |
| 40 | superoxide anion generation (GO:0042554) | 4.12725226 |
| 41 | regulation of cilium movement (GO:0003352) | 4.04713508 |
| 42 | negative regulation of mast cell activation (GO:0033004) | 3.96391861 |
| 43 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.96245451 |
| 44 | negative regulation of B cell mediated immunity (GO:0002713) | 3.96245451 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 3.95883533 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 3.94018315 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.93952442 |
| 48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.92746198 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 3.91131582 |
| 50 | negative regulation of humoral immune response (GO:0002921) | 3.83533867 |
| 51 | regulation of mast cell activation (GO:0033003) | 3.83129424 |
| 52 | ethanol oxidation (GO:0006069) | 3.82912137 |
| 53 | regulation of tolerance induction (GO:0002643) | 3.80507316 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.75950078 |
| 55 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.73652147 |
| 56 | regulation of germinal center formation (GO:0002634) | 3.72656587 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.70605811 |
| 58 | myeloid leukocyte mediated immunity (GO:0002444) | 3.63369788 |
| 59 | one-carbon compound transport (GO:0019755) | 3.62320191 |
| 60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60892440 |
| 61 | O-glycan processing (GO:0016266) | 3.59196482 |
| 62 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.57487453 |
| 63 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.57143148 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.56509001 |
| 65 | left/right axis specification (GO:0070986) | 3.49356183 |
| 66 | neutrophil chemotaxis (GO:0030593) | 3.49310327 |
| 67 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.47140978 |
| 68 | microglial cell activation (GO:0001774) | 3.45058069 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.40922250 |
| 70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38916941 |
| 71 | hypotonic response (GO:0006971) | 3.38824394 |
| 72 | neutrophil migration (GO:1990266) | 3.37870585 |
| 73 | sperm capacitation (GO:0048240) | 3.33608791 |
| 74 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.31255101 |
| 75 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.30034842 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29583530 |
| 77 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.28387504 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.28240368 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.23287133 |
| 80 | macrophage activation (GO:0042116) | 3.21418163 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 3.20828987 |
| 82 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.20474052 |
| 83 | detection of bacterium (GO:0016045) | 3.17805949 |
| 84 | regulation of cholesterol storage (GO:0010885) | 3.17238906 |
| 85 | T-helper 1 type immune response (GO:0042088) | 3.16272154 |
| 86 | response to fungus (GO:0009620) | 3.15205978 |
| 87 | phagosome maturation (GO:0090382) | 3.13974699 |
| 88 | ventricular system development (GO:0021591) | 3.13939861 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13638013 |
| 90 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11803002 |
| 91 | wound healing, spreading of epidermal cells (GO:0035313) | 3.09644849 |
| 92 | regulation of mononuclear cell migration (GO:0071675) | 3.08102005 |
| 93 | regulation of interleukin-5 production (GO:0032674) | 3.07687926 |
| 94 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05342112 |
| 95 | microtubule bundle formation (GO:0001578) | 3.05277758 |
| 96 | granulocyte chemotaxis (GO:0071621) | 3.04355990 |
| 97 | negative regulation of interleukin-17 production (GO:0032700) | 3.04070070 |
| 98 | dendritic cell migration (GO:0036336) | 3.01730079 |
| 99 | detection of biotic stimulus (GO:0009595) | 3.00954688 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.00308651 |
| 101 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99069102 |
| 102 | reactive oxygen species biosynthetic process (GO:1903409) | 2.96582226 |
| 103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.96119887 |
| 104 | response to muramyl dipeptide (GO:0032495) | 2.95664770 |
| 105 | regulation of interleukin-13 production (GO:0032656) | 2.94988876 |
| 106 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94566553 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 2.92343910 |
| 108 | granulocyte migration (GO:0097530) | 2.91902815 |
| 109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91408124 |
| 110 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.91305605 |
| 111 | regulation of activation of Janus kinase activity (GO:0010533) | 2.90041009 |
| 112 | endodermal cell differentiation (GO:0035987) | 2.88780211 |
| 113 | regulation of antigen processing and presentation (GO:0002577) | 2.88675762 |
| 114 | lipoxygenase pathway (GO:0019372) | 2.88227972 |
| 115 | low-density lipoprotein particle clearance (GO:0034383) | 2.87770874 |
| 116 | negative regulation of adaptive immune response (GO:0002820) | 2.86752518 |
| 117 | macrophage differentiation (GO:0030225) | 2.85690020 |
| 118 | positive regulation of macrophage cytokine production (GO:0060907) | 2.85621729 |
| 119 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.85158168 |
| 120 | natural killer cell mediated immunity (GO:0002228) | 2.85158168 |
| 121 | actin nucleation (GO:0045010) | 2.83582653 |
| 122 | regulation of monocyte chemotaxis (GO:0090025) | 2.82965451 |
| 123 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.82227434 |
| 124 | germinal center formation (GO:0002467) | 2.81794844 |
| 125 | B cell mediated immunity (GO:0019724) | 2.80412646 |
| 126 | dendritic cell chemotaxis (GO:0002407) | 2.79158805 |
| 127 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.78530860 |
| 128 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77466959 |
| 129 | positive regulation of mast cell degranulation (GO:0043306) | 2.77321430 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77321430 |
| 131 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.75332187 |
| 132 | phagocytosis, recognition (GO:0006910) | 2.74786869 |
| 133 | response to type I interferon (GO:0034340) | 2.74596486 |
| 134 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.74546672 |
| 135 | type I interferon signaling pathway (GO:0060337) | 2.73462515 |
| 136 | cellular response to type I interferon (GO:0071357) | 2.73462515 |
| 137 | oligosaccharide biosynthetic process (GO:0009312) | 2.73393030 |
| 138 | multicellular organismal water homeostasis (GO:0050891) | 2.71819569 |
| 139 | myeloid leukocyte activation (GO:0002274) | 2.71104036 |
| 140 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70688003 |
| 141 | negative regulation of lipid storage (GO:0010888) | 2.67592866 |
| 142 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66367870 |
| 143 | leukocyte cell-cell adhesion (GO:0007159) | 2.65244146 |
| 144 | iron ion import (GO:0097286) | 2.64251845 |
| 145 | leukocyte mediated cytotoxicity (GO:0001909) | 2.64207255 |
| 146 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.64153967 |
| 147 | wound healing, spreading of cells (GO:0044319) | 2.63728638 |
| 148 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.63684158 |
| 149 | negative regulation of cell killing (GO:0031342) | 2.63684158 |
| 150 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.60752247 |
| 151 | cilium organization (GO:0044782) | 2.59607547 |
| 152 | negative regulation of interleukin-12 production (GO:0032695) | 2.59494853 |
| 153 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.57119162 |
| 154 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56596565 |
| 155 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.53339114 |
| 156 | cilium assembly (GO:0042384) | 2.49604324 |
| 157 | negative regulation of interleukin-6 production (GO:0032715) | 2.48428334 |
| 158 | intraciliary transport (GO:0042073) | 2.46706195 |
| 159 | glomerular epithelial cell development (GO:0072310) | 2.45625430 |
| 160 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.42200296 |
| 161 | water homeostasis (GO:0030104) | 2.39720528 |
| 162 | amyloid precursor protein catabolic process (GO:0042987) | 2.39595370 |
| 163 | axonemal dynein complex assembly (GO:0070286) | 12.3215219 |
| 164 | cilium or flagellum-dependent cell motility (GO:0001539) | 10.2102452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.12020788 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.99383804 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.54453505 |
| 4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.34568702 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.12805509 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.07509742 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.82664008 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63027013 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.41945171 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.31497495 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.29789290 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77291945 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76190163 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67603912 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.64504482 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57702693 |
| 17 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.30669348 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.25938221 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.09178682 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.05497407 |
| 21 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.05275917 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03194583 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98417130 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95915554 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95511320 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.93308068 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.93286897 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90820002 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88798271 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.83404180 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81099119 |
| 32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.79446493 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78118601 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74193370 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73211552 |
| 36 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70870276 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66929489 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66579842 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66122494 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63433068 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60419321 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59877333 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.59296980 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54386343 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53440728 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52069915 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51791776 |
| 48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51340359 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.51109250 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50345159 |
| 51 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.47321092 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.47186570 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.47186570 |
| 54 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45812333 |
| 55 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.44232221 |
| 56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44077420 |
| 57 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.42969017 |
| 58 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.42969017 |
| 59 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41061432 |
| 60 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.40437610 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38344840 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.36973733 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36445005 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35484320 |
| 65 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.32907102 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32234082 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.31224202 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30245760 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30021612 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29794937 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28630435 |
| 72 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28436571 |
| 73 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28036525 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27634850 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26573106 |
| 76 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.25052246 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22851226 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21868633 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21118039 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20361651 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.16846871 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16340367 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15652711 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14072340 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13783225 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13548610 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12995992 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12813001 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.12017753 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11071370 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10741437 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10011291 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08633388 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08209650 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07812713 |
| 96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04253711 |
| 97 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.03978039 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03306887 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02295769 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01688914 |
| 101 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01084259 |
| 102 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00491053 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99838851 |
| 104 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99535652 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99271116 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98832005 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98268084 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97900656 |
| 109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.96350802 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96267771 |
| 111 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95639316 |
| 112 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94981792 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94510264 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94327251 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94017680 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93723886 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93370266 |
| 118 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93122213 |
| 119 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93093682 |
| 120 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92564020 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91252996 |
| 122 | MAF_26560356_Chip-Seq_TH1_Human | 0.89723832 |
| 123 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88891273 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87952547 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86769924 |
| 126 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85618803 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85559875 |
| 128 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.84133550 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83447214 |
| 130 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81803479 |
| 131 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79038559 |
| 132 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.78345102 |
| 133 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78312275 |
| 134 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.75617122 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75116146 |
| 136 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.75062670 |
| 137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74965080 |
| 138 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74818181 |
| 139 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73921735 |
| 140 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73795515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.26825549 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 3.57343021 |
| 3 | MP0003303_peritoneal_inflammation | 3.42141761 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.40325953 |
| 5 | MP0009785_altered_susceptibility_to | 3.39894781 |
| 6 | MP0002419_abnormal_innate_immunity | 3.25094296 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.72756986 |
| 8 | MP0006082_CNS_inflammation | 2.63407498 |
| 9 | MP0005025_abnormal_response_to | 2.55982732 |
| 10 | MP0009278_abnormal_bone_marrow | 2.52118449 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.51430132 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.48925583 |
| 13 | MP0003724_increased_susceptibility_to | 2.48437346 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.45847101 |
| 15 | MP0004043_abnormal_pH_regulation | 2.42797380 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.38527408 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.36546584 |
| 18 | MP0001853_heart_inflammation | 2.30098057 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.25950059 |
| 20 | MP0009764_decreased_sensitivity_to | 2.14629099 |
| 21 | MP0000343_altered_response_to | 2.08809770 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.06214706 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.99934201 |
| 24 | MP0005387_immune_system_phenotype | 1.98414511 |
| 25 | MP0001790_abnormal_immune_system | 1.98414511 |
| 26 | MP0003448_altered_tumor_morphology | 1.97528172 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.97117129 |
| 28 | MP0001800_abnormal_humoral_immune | 1.92568621 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.92372393 |
| 30 | MP0002405_respiratory_system_inflammati | 1.90287766 |
| 31 | MP0002723_abnormal_immune_serum | 1.89657200 |
| 32 | MP0000858_altered_metastatic_potential | 1.87460638 |
| 33 | MP0001819_abnormal_immune_cell | 1.86229462 |
| 34 | MP0003866_abnormal_defecation | 1.84589548 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.83316383 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.79709614 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.79709614 |
| 38 | MP0000685_abnormal_immune_system | 1.78010108 |
| 39 | MP0003279_aneurysm | 1.77662461 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.75280369 |
| 41 | MP0004947_skin_inflammation | 1.75239077 |
| 42 | MP0002933_joint_inflammation | 1.74128355 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.71614229 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.71293080 |
| 45 | MP0005671_abnormal_response_to | 1.66409448 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.65998167 |
| 47 | MP0010678_abnormal_skin_adnexa | 1.62601684 |
| 48 | MP0005083_abnormal_biliary_tract | 1.61100170 |
| 49 | MP0003075_altered_response_to | 1.60834208 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.57676646 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.55267245 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.52882697 |
| 53 | MP0005166_decreased_susceptibility_to | 1.51197050 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.49997190 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.49090971 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.48011248 |
| 57 | MP0005165_increased_susceptibility_to | 1.46040916 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.44114074 |
| 59 | MP0008469_abnormal_protein_level | 1.40205354 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.37047231 |
| 61 | MP0005390_skeleton_phenotype | 1.36292130 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.33305378 |
| 63 | MP0004510_myositis | 1.32725665 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.29838311 |
| 65 | MP0005164_abnormal_response_to | 1.28852916 |
| 66 | MP0002796_impaired_skin_barrier | 1.28810292 |
| 67 | MP0003828_pulmonary_edema | 1.27227990 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.26598247 |
| 69 | MP0005365_abnormal_bile_salt | 1.24210991 |
| 70 | MP0005275_abnormal_skin_tensile | 1.23021505 |
| 71 | MP0005023_abnormal_wound_healing | 1.19242331 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.17776600 |
| 73 | MP0000716_abnormal_immune_system | 1.16762993 |
| 74 | MP0000383_abnormal_hair_follicle | 1.16138278 |
| 75 | MP0004883_abnormal_blood_vessel | 1.15536984 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.14058603 |
| 77 | MP0005076_abnormal_cell_differentiation | 1.10304566 |
| 78 | MP0001851_eye_inflammation | 1.09893298 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 1.08965756 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 1.07189682 |
| 81 | MP0005310_abnormal_salivary_gland | 1.04196367 |
| 82 | MP0003795_abnormal_bone_structure | 1.03224490 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 1.02567421 |
| 84 | MP0002398_abnormal_bone_marrow | 1.02398986 |
| 85 | MP0003186_abnormal_redox_activity | 0.99685525 |
| 86 | MP0002396_abnormal_hematopoietic_system | 0.97606021 |
| 87 | MP0002254_reproductive_system_inflammat | 0.96359360 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.96020972 |
| 89 | MP0010307_abnormal_tumor_latency | 0.95515972 |
| 90 | MP0001873_stomach_inflammation | 0.95476237 |
| 91 | MP0000689_abnormal_spleen_morphology | 0.95264891 |
| 92 | MP0002168_other_aberrant_phenotype | 0.94036541 |
| 93 | MP0003690_abnormal_glial_cell | 0.93499061 |
| 94 | MP0008260_abnormal_autophagy | 0.92160644 |
| 95 | MP0002429_abnormal_blood_cell | 0.91941890 |
| 96 | MP0001664_abnormal_digestion | 0.91086844 |
| 97 | MP0009840_abnormal_foam_cell | 0.90190368 |
| 98 | MP0009763_increased_sensitivity_to | 0.88969757 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.88368007 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.88168950 |
| 101 | MP0005451_abnormal_body_composition | 0.87602459 |
| 102 | MP0006054_spinal_hemorrhage | 0.87440119 |
| 103 | MP0001984_abnormal_olfaction | 0.86709875 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.86694220 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 0.86535976 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.86197166 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.85602271 |
| 108 | MP0002006_tumorigenesis | 0.85578064 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 0.85481537 |
| 110 | MP0001958_emphysema | 0.85183945 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.83925906 |
| 112 | MP0002060_abnormal_skin_morphology | 0.83765477 |
| 113 | MP0000604_amyloidosis | 0.83455132 |
| 114 | MP0002132_abnormal_respiratory_system | 0.82712625 |
| 115 | MP0009780_abnormal_chondrocyte_physiolo | 0.81361760 |
| 116 | MP0008004_abnormal_stomach_pH | 0.81188994 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.80707150 |
| 118 | MP0000490_abnormal_crypts_of | 0.80234955 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.79944927 |
| 120 | MP0002722_abnormal_immune_system | 0.78833806 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.77192834 |
| 122 | MP0002166_altered_tumor_susceptibility | 0.76839016 |
| 123 | MP0010352_gastrointestinal_tract_polyps | 0.76078820 |
| 124 | MP0003091_abnormal_cell_migration | 0.75400317 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.74968105 |
| 126 | MP0002138_abnormal_hepatobiliary_system | 0.74871271 |
| 127 | MP0003878_abnormal_ear_physiology | 0.74684159 |
| 128 | MP0005377_hearing/vestibular/ear_phenot | 0.74684159 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.74442467 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.74237574 |
| 131 | MP0002098_abnormal_vibrissa_morphology | 0.73854938 |
| 132 | MP0001663_abnormal_digestive_system | 0.71624129 |
| 133 | MP0000249_abnormal_blood_vessel | 0.69420789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal respiratory motile cilium morphology (HP:0005938) | 9.17060187 |
| 2 | Abnormal respiratory epithelium morphology (HP:0012253) | 9.17060187 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 9.01947301 |
| 4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 9.01947301 |
| 5 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.01090911 |
| 6 | Abnormal ciliary motility (HP:0012262) | 8.72994060 |
| 7 | Rhinitis (HP:0012384) | 8.42222311 |
| 8 | Chronic bronchitis (HP:0004469) | 7.22673378 |
| 9 | Recurrent abscess formation (HP:0002722) | 6.91810843 |
| 10 | Nasal polyposis (HP:0100582) | 6.62939731 |
| 11 | Bronchiectasis (HP:0002110) | 6.61792280 |
| 12 | Eczematoid dermatitis (HP:0000976) | 6.60399911 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.06706074 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 5.82882920 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 5.71941420 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.99705536 |
| 17 | Hyperactive renin-angiotensin system (HP:0000841) | 4.61353512 |
| 18 | Orchitis (HP:0100796) | 4.51274611 |
| 19 | Myositis (HP:0100614) | 4.38652060 |
| 20 | Bronchitis (HP:0012387) | 4.34156779 |
| 21 | Recurrent sinusitis (HP:0011108) | 4.30378911 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 4.26322935 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 4.23695684 |
| 24 | Optic neuritis (HP:0100653) | 4.16315538 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 4.16315538 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.95525714 |
| 27 | Obstructive lung disease (HP:0006536) | 3.95525714 |
| 28 | Gingivitis (HP:0000230) | 3.93980530 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 3.85185408 |
| 30 | Chronic sinusitis (HP:0011109) | 3.84405042 |
| 31 | Recurrent skin infections (HP:0001581) | 3.68104543 |
| 32 | Stomatitis (HP:0010280) | 3.60208137 |
| 33 | Myocardial infarction (HP:0001658) | 3.55096310 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.53199512 |
| 35 | Recurrent otitis media (HP:0000403) | 3.52734373 |
| 36 | Chronic otitis media (HP:0000389) | 3.52467630 |
| 37 | Male infertility (HP:0003251) | 3.51786414 |
| 38 | Infertility (HP:0000789) | 3.47822204 |
| 39 | Recurrent fungal infections (HP:0002841) | 3.27526136 |
| 40 | Urticaria (HP:0001025) | 3.24171618 |
| 41 | Prostate neoplasm (HP:0100787) | 3.20845738 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 3.05512619 |
| 43 | Axonal loss (HP:0003447) | 2.99512598 |
| 44 | Hepatosplenomegaly (HP:0001433) | 2.92187609 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.91486455 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90289915 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.90289915 |
| 48 | Decreased circulating renin level (HP:0003351) | 2.81591320 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79618381 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79618381 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79618381 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 2.76924480 |
| 53 | Abnormal platelet volume (HP:0011876) | 2.66085676 |
| 54 | Arterial thrombosis (HP:0004420) | 2.66007128 |
| 55 | Joint hemorrhage (HP:0005261) | 2.64444393 |
| 56 | Disinhibition (HP:0000734) | 2.63347198 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60518312 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60518312 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58868253 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58456653 |
| 61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58456653 |
| 62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58456653 |
| 63 | Periodontitis (HP:0000704) | 2.58307055 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.50392878 |
| 65 | Vasculitis (HP:0002633) | 2.50234258 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.45894277 |
| 67 | Increased IgE level (HP:0003212) | 2.45198922 |
| 68 | Abnormality of renin-angiotensin system (HP:0000847) | 2.42493519 |
| 69 | Pustule (HP:0200039) | 2.42446307 |
| 70 | Cellulitis (HP:0100658) | 2.41106955 |
| 71 | Abnormality of the lumbar spine (HP:0100712) | 2.39453976 |
| 72 | Thick nail (HP:0001805) | 2.36861445 |
| 73 | Gingival bleeding (HP:0000225) | 2.36336639 |
| 74 | Meningitis (HP:0001287) | 2.35816397 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.35801617 |
| 76 | Abnormality of chloride homeostasis (HP:0011422) | 2.31187024 |
| 77 | Cheilitis (HP:0100825) | 2.31043289 |
| 78 | Osteomyelitis (HP:0002754) | 2.30766283 |
| 79 | Atelectasis (HP:0100750) | 2.30184846 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.28216302 |
| 81 | Hyperaldosteronism (HP:0000859) | 2.25965528 |
| 82 | Basal ganglia calcification (HP:0002135) | 2.25718067 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.25417255 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.24747890 |
| 85 | Renal salt wasting (HP:0000127) | 2.24730174 |
| 86 | Hemoptysis (HP:0002105) | 2.22205249 |
| 87 | Loss of speech (HP:0002371) | 2.18225853 |
| 88 | Cervical subluxation (HP:0003308) | 2.17081846 |
| 89 | Petechiae (HP:0000967) | 2.13953097 |
| 90 | Occipital encephalocele (HP:0002085) | 2.13796692 |
| 91 | Anorexia (HP:0002039) | 2.07995078 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 2.07770815 |
| 93 | Tetraparesis (HP:0002273) | 2.05974049 |
| 94 | Gangrene (HP:0100758) | 2.04726157 |
| 95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03712138 |
| 96 | Leukocytosis (HP:0001974) | 2.03556001 |
| 97 | Thickened calvaria (HP:0002684) | 2.02115345 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.01314722 |
| 99 | Vertebral compression fractures (HP:0002953) | 2.00666263 |
| 100 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 10.3214024 |
| 101 | Osteolytic defects of the hand bones (HP:0009699) | 1.98206445 |
| 102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98206445 |
| 103 | True hermaphroditism (HP:0010459) | 1.98195449 |
| 104 | Spontaneous hematomas (HP:0007420) | 1.97608892 |
| 105 | Pancreatic fibrosis (HP:0100732) | 1.96468396 |
| 106 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.96216966 |
| 107 | Menorrhagia (HP:0000132) | 1.96192504 |
| 108 | Hyperkalemia (HP:0002153) | 1.96092180 |
| 109 | Epiphyseal dysplasia (HP:0002656) | 1.94309654 |
| 110 | Skin ulcer (HP:0200042) | 1.90952654 |
| 111 | Glomerulopathy (HP:0100820) | 1.89860939 |
| 112 | Tubulointerstitial nephritis (HP:0001970) | 1.89021521 |
| 113 | Epistaxis (HP:0000421) | 1.87460533 |
| 114 | Absent frontal sinuses (HP:0002688) | 1.86876929 |
| 115 | Peritonitis (HP:0002586) | 1.86750678 |
| 116 | Gastrointestinal infarctions (HP:0005244) | 1.86438779 |
| 117 | Flat acetabular roof (HP:0003180) | 1.85522570 |
| 118 | Nausea (HP:0002018) | 1.84712645 |
| 119 | Glomerulonephritis (HP:0000099) | 1.84706759 |
| 120 | Interstitial pulmonary disease (HP:0006530) | 1.83494452 |
| 121 | Thoracic kyphosis (HP:0002942) | 1.82719070 |
| 122 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82465110 |
| 123 | Encephalitis (HP:0002383) | 1.81272403 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81028109 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.80302861 |
| 126 | Hematochezia (HP:0002573) | 1.79517285 |
| 127 | Beaking of vertebral bodies (HP:0004568) | 1.78980396 |
| 128 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.75849501 |
| 129 | Agnosia (HP:0010524) | 1.75449807 |
| 130 | Submucous cleft hard palate (HP:0000176) | 1.74987528 |
| 131 | Albinism (HP:0001022) | 1.74071880 |
| 132 | Hyponatremia (HP:0002902) | 1.73239061 |
| 133 | Keratitis (HP:0000491) | 1.71684412 |
| 134 | Pathologic fracture (HP:0002756) | 1.71529141 |
| 135 | Nephritis (HP:0000123) | 1.71305608 |
| 136 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71087573 |
| 137 | Cystic liver disease (HP:0006706) | 1.70206957 |
| 138 | Amyloidosis (HP:0011034) | 1.69079036 |
| 139 | Nephropathy (HP:0000112) | 1.57094638 |
| 140 | Cone-rod dystrophy (HP:0000548) | 1.55372128 |
| 141 | Pancreatic cysts (HP:0001737) | 1.53482796 |
| 142 | Malnutrition (HP:0004395) | 1.51722560 |
| 143 | Purpura (HP:0000979) | 1.49368374 |
| 144 | Ventricular fibrillation (HP:0001663) | 1.48019783 |
| 145 | Tubular atrophy (HP:0000092) | 1.45699020 |
| 146 | Molar tooth sign on MRI (HP:0002419) | 1.43676158 |
| 147 | Abnormality of midbrain morphology (HP:0002418) | 1.43676158 |
| 148 | Nephronophthisis (HP:0000090) | 1.40689060 |
| 149 | Distal lower limb muscle weakness (HP:0009053) | 1.34136536 |
| 150 | Furrowed tongue (HP:0000221) | 1.32718274 |
| 151 | Hypokalemic alkalosis (HP:0001949) | 1.31137049 |
| 152 | Chronic hepatic failure (HP:0100626) | 1.30042206 |
| 153 | Congenital hepatic fibrosis (HP:0002612) | 1.28893937 |
| 154 | Increased serum ferritin (HP:0003281) | 1.28151077 |
| 155 | Alkalosis (HP:0001948) | 1.26147932 |
| 156 | Abnormality of sodium homeostasis (HP:0010931) | 1.25769499 |
| 157 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.24482072 |
| 158 | Short nail (HP:0001799) | 1.23903364 |
| 159 | Abnormality of the renal medulla (HP:0100957) | 1.23432648 |
| 160 | Glucose intolerance (HP:0000833) | 1.22905731 |
| 161 | Hypotension (HP:0002615) | 1.22832903 |
| 162 | Adrenal overactivity (HP:0002717) | 1.21803004 |
| 163 | Hemorrhage of the eye (HP:0011885) | 1.20793781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.78882183 |
| 2 | EPHA2 | 5.28421484 |
| 3 | IRAK4 | 3.65503337 |
| 4 | IRAK3 | 3.40537503 |
| 5 | MAP3K14 | 3.04925243 |
| 6 | RIPK4 | 2.76649406 |
| 7 | TRPM7 | 2.74296403 |
| 8 | BLK | 2.67234773 |
| 9 | MAP3K3 | 2.34371772 |
| 10 | PBK | 2.33405307 |
| 11 | TBK1 | 2.31133022 |
| 12 | MAP3K2 | 2.27761365 |
| 13 | TEC | 2.23208812 |
| 14 | ERBB3 | 2.15156816 |
| 15 | KIT | 2.01732954 |
| 16 | ERN1 | 1.97023403 |
| 17 | BTK | 1.95593889 |
| 18 | TYK2 | 1.92931003 |
| 19 | NEK9 | 1.90532573 |
| 20 | TXK | 1.85708833 |
| 21 | CSK | 1.82430458 |
| 22 | IKBKB | 1.78227756 |
| 23 | EPHB1 | 1.74743294 |
| 24 | MAP2K3 | 1.72569439 |
| 25 | HCK | 1.71808940 |
| 26 | TGFBR2 | 1.69119354 |
| 27 | JAK3 | 1.66510438 |
| 28 | TAOK1 | 1.56909739 |
| 29 | STK10 | 1.52071848 |
| 30 | PIM2 | 1.49934082 |
| 31 | IKBKE | 1.49272345 |
| 32 | FGR | 1.48062852 |
| 33 | RPS6KA4 | 1.41856845 |
| 34 | GRK6 | 1.39676754 |
| 35 | PTK6 | 1.34283030 |
| 36 | TRIB3 | 1.27986897 |
| 37 | TAOK3 | 1.25311647 |
| 38 | RIPK1 | 1.24820716 |
| 39 | NME2 | 1.24432836 |
| 40 | ITK | 1.23956414 |
| 41 | JAK1 | 1.20531378 |
| 42 | MAPKAPK3 | 1.18250423 |
| 43 | PRKG2 | 1.17910676 |
| 44 | SMG1 | 1.16153721 |
| 45 | ACVR1B | 1.13870939 |
| 46 | MAP4K1 | 1.13639037 |
| 47 | CSF1R | 1.11019947 |
| 48 | FGFR3 | 1.10222706 |
| 49 | PIK3CA | 1.06587309 |
| 50 | PTK2B | 1.06025552 |
| 51 | MST4 | 1.02849243 |
| 52 | ZAP70 | 1.02338499 |
| 53 | LMTK2 | 1.01934108 |
| 54 | LYN | 1.01222966 |
| 55 | SIK3 | 1.00053976 |
| 56 | FRK | 0.99733015 |
| 57 | MARK3 | 0.98480705 |
| 58 | NUAK1 | 0.96907006 |
| 59 | MAP3K13 | 0.96896666 |
| 60 | TTN | 0.96735426 |
| 61 | YES1 | 0.95304285 |
| 62 | TNK2 | 0.93609797 |
| 63 | CHUK | 0.92470010 |
| 64 | SYK | 0.91970358 |
| 65 | MAP3K1 | 0.91207396 |
| 66 | FES | 0.90823894 |
| 67 | PAK4 | 0.90790906 |
| 68 | STK3 | 0.86217769 |
| 69 | PDPK1 | 0.85929345 |
| 70 | EIF2AK2 | 0.84762994 |
| 71 | LCK | 0.84602872 |
| 72 | EPHA3 | 0.83071480 |
| 73 | MAP3K12 | 0.82741632 |
| 74 | PIM1 | 0.81281417 |
| 75 | PTK2 | 0.79711251 |
| 76 | MST1R | 0.76923459 |
| 77 | MET | 0.76123399 |
| 78 | BMX | 0.76015973 |
| 79 | PRKCD | 0.74933305 |
| 80 | ABL2 | 0.74270778 |
| 81 | MARK2 | 0.74261280 |
| 82 | ABL1 | 0.73316581 |
| 83 | STK4 | 0.73015837 |
| 84 | LRRK2 | 0.72753141 |
| 85 | JAK2 | 0.71946329 |
| 86 | CAMK1D | 0.69820862 |
| 87 | MAP3K7 | 0.69608007 |
| 88 | GRK7 | 0.67146513 |
| 89 | CDC42BPA | 0.66061553 |
| 90 | PKN2 | 0.65724697 |
| 91 | CLK1 | 0.65063844 |
| 92 | EGFR | 0.65058702 |
| 93 | PDK1 | 0.63546674 |
| 94 | KSR2 | 0.63007945 |
| 95 | EIF2AK3 | 0.62609641 |
| 96 | NME1 | 0.62475703 |
| 97 | EPHB2 | 0.61034217 |
| 98 | MAP3K6 | 0.59118747 |
| 99 | MAPKAPK2 | 0.59111038 |
| 100 | PRKCQ | 0.58878838 |
| 101 | ZAK | 0.57770307 |
| 102 | CAMKK2 | 0.57483734 |
| 103 | NEK6 | 0.57396695 |
| 104 | BMPR2 | 0.56334949 |
| 105 | MOS | 0.56167883 |
| 106 | GRK1 | 0.54903149 |
| 107 | MAP2K6 | 0.54330903 |
| 108 | IRAK2 | 0.53363961 |
| 109 | TAOK2 | 0.53313132 |
| 110 | FGFR4 | 0.51328967 |
| 111 | CDK6 | 0.51219641 |
| 112 | ADRBK2 | 0.51105068 |
| 113 | MATK | 0.50385152 |
| 114 | PRPF4B | 0.49715288 |
| 115 | IRAK1 | 0.49167934 |
| 116 | STK24 | 0.48518465 |
| 117 | PIK3CG | 0.48226499 |
| 118 | MAP3K11 | 0.46330955 |
| 119 | IGF1R | 0.45684043 |
| 120 | FYN | 0.44988111 |
| 121 | FER | 0.44684287 |
| 122 | BMPR1B | 0.44563810 |
| 123 | PRKAA2 | 0.43827660 |
| 124 | ERBB4 | 0.43178775 |
| 125 | TESK1 | 0.42358642 |
| 126 | MAP3K5 | 0.41229027 |
| 127 | CASK | 0.41092608 |
| 128 | STK38 | 0.39786208 |
| 129 | PRKCH | 0.38668564 |
| 130 | SGK3 | 0.38180966 |
| 131 | RPS6KA6 | 0.36197758 |
| 132 | SGK2 | 0.35705411 |
| 133 | MAPK11 | 0.34606261 |
| 134 | CAMKK1 | 0.31946765 |
| 135 | PDGFRB | 0.30425051 |
| 136 | ERBB2 | 0.30225534 |
| 137 | HIPK2 | 0.30042212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.52802407 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.40152230 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.84238690 |
| 4 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.48858093 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.43222553 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39265647 |
| 7 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.39181497 |
| 8 | Phagosome_Homo sapiens_hsa04145 | 2.37095445 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.29280128 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.21380145 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.19279626 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11124081 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10533394 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.09852119 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.07314281 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.07150615 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.04337311 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.99512797 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88878675 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.84644669 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70356865 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65366860 |
| 23 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.65153890 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64746862 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64508937 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64405705 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.64009771 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.60956776 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.59533699 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.57711838 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.54978921 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54013218 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52159988 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.49787322 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49433292 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47049088 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41598188 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39217434 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33406723 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31727415 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31033957 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27510777 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.26499927 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.25378308 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24616216 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22989557 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19868169 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17879211 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15927651 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14657785 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14142256 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.13752129 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13509468 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.12313427 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 1.11857819 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03804564 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02250717 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93565674 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90712585 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89863550 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.88331993 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87936147 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87831560 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87577921 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86694199 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86299864 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85614762 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84298516 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84103049 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83423110 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82643479 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82087783 |
| 73 | * Retinol metabolism_Homo sapiens_hsa00830 | 0.81415421 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80920209 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80032056 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79458818 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78432206 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76663555 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.76433496 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76200538 |
| 81 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74861084 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74170036 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73378577 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71135244 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71088298 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71072679 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70638608 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69456702 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63504930 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62247682 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59923170 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59737394 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.58434351 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57281080 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55653545 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54541512 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53873979 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.53756037 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52521429 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.52052825 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51688639 |
| 102 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50923044 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50639930 |
| 104 | Melanoma_Homo sapiens_hsa05218 | 0.48380607 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.48210552 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47433337 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46844092 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45323257 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45122828 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44587666 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44050136 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.43639205 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43227413 |
| 114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40270537 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40199388 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.39595543 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38140320 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.37207719 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34901979 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34691255 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33773370 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32488280 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32306104 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31142406 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.28619416 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.26323188 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26313992 |

